Litcius/Paper detail

Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors

Oded Icht, Naama Darzi, Shai Shimony, Oded Jacobi, Daniel Reinhorn, Yosef Landman, Raz Mutai, Itamar Averbuch, Tzippy Shochat, Galia Spectre, Pia Raanani, Ofer Rotem, Elizabeth Dudnik, Nir Peled, Alona Zer, Avi Leader

2021Journal of Thrombosis and Haemostasis61 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineHazard ratioLung cancerChemotherapyCumulative incidenceIncidence (geometry)Retrospective cohort studyCohortCohort studyOncologyCancerSurgeryConfidence intervalPhysicsOpticsVenous Thromboembolism Diagnosis and ManagementInflammatory Biomarkers in Disease PrognosisChemotherapy-induced cardiotoxicity and mitigation
Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors | Litcius